![IMA new masthead1](https://prodcraftsa01.blob.core.windows.net/assets/products/internal-medicine-alert/_contentImage/IMA_new_masthead1.png)
Internal Medicine Alert – June 30, 2011
June 30, 2011
View Issues
-
I Can't Get No Salivation
Elders who ate sorbet before a meal ate more of the rest of their meal. -
Desperate Diseases Call for Drastic Diets
A very low energy diet followed by a weight maintenance program results in significant improvements in weight, obstructive sleep apnea, metabolic factors, and quality for at least a year. -
Proton Pump Inhibitors and Clopidogrel
Proton pump inhibitor use in clopidogrel-treated post-percutaneous coronary intervention patients was not associated with an increased risk of all-cause death, nonfatal myocardial infarction, repeat revascularization, or major adverse cardiovascular events. -
Telaprevir Film-Coated Tablets (Incivek™)
A second NS3/4A protease inhibitor has been approved by the FDA for the treatment of chronic hepatitis C (HCV) genotype 1, joining the recently approved boceprevir (Victrelis). Telaprevir is marketed by Vertex Pharmaceuticals as Incivek. -
Clinical Briefs by Louis Kuritzky, MD